My first 50 days here reaffirm all of this. There are many other reasons why I returned to Bausch + Lomb, an iconic brand 170 years in the making, a broad, diverse commercial platform, products that touch patients throughout their lives a massive global infrastructure, and a competitive landscape where we have the most comprehensive footprint and most importantly, a team of talented and dedicated colleagues who are passionate about making Bausch + Lomb the best eye health company in the world. Companies that can meet these needs are rewarded for innovation in a favorable competitive environment with significant barriers to entry. The eye health industry operates an attractive part of the health care space with a large addressable market and growth driven by demographic trends and lifestyle changes that create significant unmet needs. Having an opportunity to work in this great industry again was an important factor in my decision to rejoin Bausch + Lomb. It is an area that I care deeply about and have continued to stay close to. It's a dynamic industry that is always evolving, full of innovation and collaboration and with many talented practitioners, surgeons, ophthalmologists, optometrists and significant unmet needs for millions of people. I've been involved in eye health for the better part of my career. Finally, I'll cover our key franchises and a few upcoming catalysts before opening the line for questions.īeginning with Slide three. I will then turn the call over to Sam, our CFO, to review the first quarter financial results in detail and discuss our 2023 guidance. I'll start off by sharing some high-level comments about my first 50 days as Chairman and CEO of Bausch + Lomb and briefly discuss the first quarter financial highlights. Thank you, Allison, and thank you, everyone, for joining us today. With that, it is my pleasure to turn the call over to Brent. It is our policy to generally not update guidance until the following quarter unless required by law and to not update or affirm guidance other than through broadly disseminated public disclosure. ![]() Non-GAAP reconciliations can be found in the appendix to the presentation posted on our website.įinally, the financial guidance in this presentation is effective as of today only. For more information about these measures and ratios, please refer to Slide one of the presentation. This presentation contains non-GAAP financial measures and ratios. We would ask that you take a moment to read the forward-looking legend at the beginning of our presentation as it contains important information. In addition to this live webcast, a copy of today's slide presentation and a replay of this conference call will be available on our website under the Investor Relations section.īefore we begin, I would like to remind you that our presentation today contains forward-looking information. Brent Saunders and Chief Financial Officer, Mr. Participating on today's call are Chairman and Chief Executive Officer, Mr. Good morning, everyone, and welcome to our first quarter 2023 financial results conference call. I would now like to turn the conference over to Allison Ryan. ![]() ![]() Please note this event is being recorded. All participants will be listen-only mode. ![]() Good morning, and welcome to the Bausch + Lomb's First Quarter 2023 Earnings Call. Bausch + Lomb Corporation ( NYSE: BLCO) Q1 2023 Earnings Conference Call 8:00 AM ETĬraig Bijou - Bank of America Merrill Lynch
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |